Tessera Therapeutics names former Merck executive as new CEO
Go back to Tessera Therapeutics names former Merck executive as new CEO| Merck & Co. (NYSE: MRK) | Delayed: 130.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.20 | 52 Week High | $65.46 | |||
| Open | $130.20 | 52 Week Low | $47.97 | |||
| Day High | $130.20 | P/E | 88.57 | |||
| Day Low | $130.20 | EPS | $1.47 | |||
| Volume | 5,184 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 762.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $762.63 | 52 Week High | $592.36 | |||
| Open | $762.63 | 52 Week Low | $325.35 | |||
| Day High | $762.63 | P/E | 200.17 | |||
| Day Low | $762.63 | EPS | $3.81 | |||
| Volume | 129 | |||||
